The pandemic of COVID-19 disease in the late 2019 resulted massive screening for drug discovery purpose. However, there is still no reports about ability natural products from bacterial group class Actinobacteria as inhibitor. aim this research to identify potential compounds Actinomadura sp., member Actinobacteria, against two receptors protease with PDB ID 6LU7 and 5R7Y. eleven were docked us...